Skyclarys is the first approved therapy demonstrated to slow disease progression.
A Midlands TD is calling for advances in treatment for a rare disease to be made publicly accessible.
In Ireland, about 200 people have Friedreich’s ataxia, a rare inherited disorder that progressively affects the spinal cord and nerves, causing worsening coordination and hearing problems.
Skyclarys is the first approved treatment shown to slow progression, with some doctors reporting up to a 50% reduction in its rate.
The drug was approved in Europe in February 2024, and is already reimbursed in Spain, France, and Italy.
Longford Westmeath TD Micheál Carrigy says he wants progress to be made as soon as possible:
Doctor Spared Jail After Defective Tyre Triggered Crash Which Fatally Injured Daughter
€13,750 Awarded To Midlands Festivals Under Government Funding Scheme
Midlands MEP Seeks Gender-Focused CAP Reform
Countdown On For Ireland's Biggest One-Day Agri Show
Westmeath Marital Rape Victim Speaks Out After Husband Jailed For 10 Years
Offaly Town Set To Come Alive With Annual Dancing At The Crossroads
Laois Community Safety Partnership Seek Joint Letter On E-Scooter Ban
Uisce Éireann Set To Carry Out Upgrade Works In Offaly Town